1. Home
  2. MRNA vs ERJ Comparison

MRNA vs ERJ Comparison

Compare MRNA & ERJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRNA
  • ERJ
  • Stock Information
  • Founded
  • MRNA 2010
  • ERJ 1969
  • Country
  • MRNA United States
  • ERJ Brazil
  • Employees
  • MRNA N/A
  • ERJ N/A
  • Industry
  • MRNA Biotechnology: Biological Products (No Diagnostic Substances)
  • ERJ Aerospace
  • Sector
  • MRNA Health Care
  • ERJ Industrials
  • Exchange
  • MRNA Nasdaq
  • ERJ Nasdaq
  • Market Cap
  • MRNA 10.9B
  • ERJ 11.0B
  • IPO Year
  • MRNA 2018
  • ERJ 2000
  • Fundamental
  • Price
  • MRNA $24.47
  • ERJ $60.18
  • Analyst Decision
  • MRNA Hold
  • ERJ Buy
  • Analyst Count
  • MRNA 19
  • ERJ 5
  • Target Price
  • MRNA $43.50
  • ERJ $55.75
  • AVG Volume (30 Days)
  • MRNA 9.9M
  • ERJ 1.5M
  • Earning Date
  • MRNA 11-06-2025
  • ERJ 11-07-2025
  • Dividend Yield
  • MRNA N/A
  • ERJ 0.08%
  • EPS Growth
  • MRNA N/A
  • ERJ 11.89
  • EPS
  • MRNA N/A
  • ERJ 0.53
  • Revenue
  • MRNA $3,078,000,000.00
  • ERJ $7,305,193,434.00
  • Revenue This Year
  • MRNA N/A
  • ERJ N/A
  • Revenue Next Year
  • MRNA $10.17
  • ERJ $11.48
  • P/E Ratio
  • MRNA N/A
  • ERJ $112.36
  • Revenue Growth
  • MRNA N/A
  • ERJ 40.55
  • 52 Week Low
  • MRNA $23.15
  • ERJ $32.26
  • 52 Week High
  • MRNA $79.96
  • ERJ $61.65
  • Technical
  • Relative Strength Index (RSI)
  • MRNA 38.50
  • ERJ 63.19
  • Support Level
  • MRNA $23.78
  • ERJ $55.29
  • Resistance Level
  • MRNA $25.48
  • ERJ $61.39
  • Average True Range (ATR)
  • MRNA 1.09
  • ERJ 1.39
  • MACD
  • MRNA 0.05
  • ERJ 0.28
  • Stochastic Oscillator
  • MRNA 25.00
  • ERJ 82.52

About MRNA Moderna Inc.

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.

About ERJ Embraer S.A.

Embraer SA based in Sao Paulo, Brazil, manufacturer of jets. Its focus is to achieve customer satisfaction with and services addressing the commercial airline, executive jets, and defense and security markets. It has developed a customer-centric technology-driven portfolio of commercial aviation products and services that allows it to build long-term relationships with clients in the commercial aviation, executive jets, and defense and security markets. It operates through the various segments namely Commercial Aviation, Defense and Security, Executive Aviation, Service and Support, and Other Segments. The company generates maximum revenue from the Commercial Aviation segment.

Share on Social Networks: